339 related articles for article (PubMed ID: 30391834)
1. Sex, THC, and hormones: Effects on density and sensitivity of CB
Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
[TBL] [Abstract][Full Text] [Related]
2. Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.
Burston JJ; Wiley JL; Craig AA; Selley DE; Sim-Selley LJ
Br J Pharmacol; 2010 Sep; 161(1):103-12. PubMed ID: 20718743
[TBL] [Abstract][Full Text] [Related]
3. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
4. The impact of gonadal hormones on cannabinoid dependence.
Marusich JA; Craft RM; Lefever TW; Wiley JL
Exp Clin Psychopharmacol; 2015 Aug; 23(4):206-16. PubMed ID: 26237318
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands.
Ginsburg BC; Hensler JG
Pharmacol Biochem Behav; 2022 Feb; 213():173339. PubMed ID: 35077729
[TBL] [Abstract][Full Text] [Related]
6. Sex, species and age: Effects of rodent demographics on the pharmacology of ∆
Wiley JL; Barrus DG; Farquhar CE; Lefever TW; Gamage TF
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110064. PubMed ID: 32810571
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
8. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
9. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
[TBL] [Abstract][Full Text] [Related]
10. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
11. ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.
Lazenka MF; Selley DE; Sim-Selley LJ
Neuropharmacology; 2014 Feb; 77():224-33. PubMed ID: 24090766
[TBL] [Abstract][Full Text] [Related]
12. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
13. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
[TBL] [Abstract][Full Text] [Related]
14. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D
Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897
[TBL] [Abstract][Full Text] [Related]
17. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
Breivogel CS; Vaghela MS
J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
[TBL] [Abstract][Full Text] [Related]
18. Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history.
Dow-Edwards D; Frank A; Wade D; Weedon J; Izenwasser S
Neurotoxicol Teratol; 2016; 58():31-39. PubMed ID: 27634313
[TBL] [Abstract][Full Text] [Related]
19. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
